- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01630980
Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome
Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome: A Systematic Review and Meta-analysis of Controlled Dietary Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios and walnuts)are an important source of unsaturated fatty acids, vegetable protein, and fibre, as well as minerals, vitamins, and phytonutrients. Although the dietary guidelines for Americans and American Heart Association (AHA) recommend the consumption of nuts for cardiovascular risk reduction and the US Food and Drug Administration (FDA) issued a qualified coronary heart disease (CHD) risk reduction claim for nuts, none of the diabetes associations have addressed nuts in their most recent recommendations. This omission is despite CHD being a major cause of death in diabetes. Several trials have been undertaken in diabetes, some of which, including the largest to date by our group, have demonstrated advantages in glycemic control. Although the remaining trials have failed to show a significant improvement in glycemic control, the direction of the effect has favored nuts, along with improvements in complementary markers of metabolic control.
Need for a review: The lack of high quality data in this area to support diabetes recommendations represents an urgent call for stronger evidence. A systematic review and meta-analysis of controlled feeding trials remains the "Gold Standard" of evidence for nutrition guidelines development.
Objective: To provide evidence-based guidance for diabetes guidelines, we will conduct two systematic reviews and meta-analyses of controlled feeding trials to assess the effect of tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios and walnuts) on cardiometabolic control: (1) "Tree nuts and glycemic control" and (2) "Tree nuts and features of the metabolic syndrome".
Design: The planning and conduct of the proposed meta-analyses will follow the Cochrane handbook for systematic reviews of interventions. The reporting will follow the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
Data sources: MEDLINE, EMBASE, CINAHL and The Cochrane Central Register of Controlled Trials will be searched using appropriate search terms.
Study selection: Intervention trials that investigate the effect of exchanging nuts for other diets on cardiometabolic risk outcomes in humans will be included. Studies that are <3-weeks diet duration, lack a control, or report non-isocaloric comparisons will be excluded.
Data extraction: Independent investigators (≥2) will extract information about study design, sample size, subject characteristics, nut form, dose, follow-up, and the composition of the background diets. Mean±SEM values will be extracted for all endpoints. Standard computations and imputations will be used to derive missing variance data. Risk of bias and study quality will be assessed using the risk of bias tool and the Heyland Methodological Quality Score (MQS), respectively.
Outcomes: The two proposed analyses will assess a set of outcomes related to a different area of cardiometabolic control: (1) glycemic control (glycated blood proteins[HbA1c, fructosamine, glycated albumin], fasting glucose, fasting insulin, and the homeostasis model assessment of insulin resistance [HOMA-IR]) and (2) harmonized metabolic syndrome features (waist circumference, TG, HDL-C, blood pressure, fasting glucose).
Data synthesis: Pooled analyses will be conducted using the Generic Inverse Variance method with random effects models. Random-effects models will be used even in the absence of statistically significant between-study heterogeneity, as they yield more conservative summary effect estimates in the presence of residual heterogeneity. Exceptions will be made for the use of fixed-effects models where there is <5 included trials irrespective of heterogeneity or small trials are being pooled with larger more precise trials in the absence of statistically significant heterogeneity. Paired analyses will be applied to all crossover trials. Heterogeneity will be tested by Cochrane's Q and quantified by I2. Sources of heterogeneity will be explored by sensitivity and subgroup analyses. A priori subgroup analyses will include nut type, nut dose, duration of follow-up, change in saturated fat intake, change in dietary fibre intake, design (crossover, parallel), study quality, and baseline endpoint values. Significant unexplained heterogeneity will be investigated by additional post hoc subgroup analyses (e.g. age, sex, level of feeding control [metabolic, supplemented, dietary advice], washout in crossover trials, energy balance of the background diet, composition of the background diet [total % energy from fat, carbohydrate, protein], change in cholesterol intake, change in glycemic index, etc.). Meta-regression analyses will assess the significance of subgroups analyses. Publication bias will be investigated by the inspection of funnel plots and application of Egger's and Begg's tests.
Knowledge translation plan: Results from the two systematic reviews and meta-analyses will be disseminated through traditional means such as interactive presentations at local, national, and international scientific meetings and publication in high impact factor journals. Innovative means such as webcasts with e-mail feedback mechanisms will also be used. Knowledge Users will act as knowledge brokers networking among opinion leaders and different adopter groups to increase awareness at each stage. Two of the applicants (JLS, CWCK) will also participate directly as members of nutrition guidelines committees the 2013 CDA Clinical Practice Guidelines (CPG) for nutrition therapy by one of the applicants (JLS) and 2015 European Association for the Study of Diabetes (EASD) CPG for nutrition therapy (JLS, CWCK). Target adopters will include the clinical practice, public health, industry, research communities, and patient groups. Feedback will be incorporated and used to guide analyses and improve key messages at each stage.
Significance: The two proposed systematic reviews and meta-analyses will aid in knowledge translation related to the effects of tree nuts in diabetes and metabolic syndrome, strengthening the evidence-base for dietary recommendations and health claims.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5C 2T2
- The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Dietary trials in humans
- Randomized treatment allocation
- >=3-weeks
- Suitable control (i.e. isocaloric exchange of other dietary components for tree nuts)
- viable endpoint data
Exclusion Criteria:
- Non-human studies
- Nonrandomized treatment allocation
- 3-weeks
- Lack of a suitable control (non-isocaloric)
- no viable endpoint data
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic control measures
Time Frame: Up to 1.5-years
|
Glycated blood proteins (HbA1c, total glycated hemoglobin, fructosamine, glycated albumin), fasting glucose, fasting insulin, and the homeostasis model assessment of insulin resistance (HOMA-IR)
|
Up to 1.5-years
|
Metabolic syndrome measures
Time Frame: Up to 1.5-years
|
Harmonized metabolic syndrome diagnostic measures (waist circumference, TG, HDL-C, blood pressure, fasting glucose)
|
Up to 1.5-years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Cyril WC Kendall, PhD, Department of Nutritional Sciences and Medicine, University of Toronto and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital
Publications and helpful links
General Publications
- Jenkins DJ, Kendall CW, Banach MS, Srichaikul K, Vidgen E, Mitchell S, Parker T, Nishi S, Bashyam B, de Souza R, Ireland C, Josse RG. Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care. 2011 Aug;34(8):1706-11. doi: 10.2337/dc11-0338. Epub 2011 Jun 29.
- Blanco Mejia S, Kendall CW, Viguiliouk E, Augustin LS, Ha V, Cozma AI, Mirrahimi A, Maroleanu A, Chiavaroli L, Leiter LA, de Souza RJ, Jenkins DJ, Sievenpiper JL. Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2014 Jul 29;4(7):e004660. doi: 10.1136/bmjopen-2013-004660.
- Viguiliouk E, Kendall CW, Blanco Mejia S, Cozma AI, Ha V, Mirrahimi A, Jayalath VH, Augustin LS, Chiavaroli L, Leiter LA, de Souza RJ, Jenkins DJ, Sievenpiper JL. Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials. PLoS One. 2014 Jul 30;9(7):e103376. doi: 10.1371/journal.pone.0103376. eCollection 2014. Erratum In: PLoS One. 2014;9(9):e109224.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- INC 2012 KRS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Tree nuts
-
University of California, Los AngelesCompleted
-
John SievenpiperThe Physicians' Services Incorporated FoundationCompletedObesity | Overweight | Body Weight | Adiposity | Obesity, AbdominalCanada
-
University of TorontoUnknownCardiovascular Disease | Type 2 Diabetes | Diet TherapyCanada
-
Medical University of WarsawNutricia Foundation; Thermo Fisher Scientific, IncRecruitingAtopic Dermatitis | Peanut Allergy | Food Allergy | Tree Nut AllergyPoland
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS)Completed
-
ALK-Abelló A/SCompletedBirch Pollen AllergyFinland, Netherlands
-
King's College LondonUnknown
-
San Diego State UniversityRecruiting
-
Monash UniversityRecruiting
-
Fu Jen Catholic UniversityCompleted